Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health on Thursday began offering a much cheaper $49 compounded version of Novo Nordisk's new Wegovy weight-loss ...

Demand for GLP-1 drugs continues to climb, boosted by a major price drop and the FDA’s approval of an oral Wegovy pill that ...

A new weight-loss pill was pulled from the market just two days after its ...

Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...

How does the new Wegovy pill compare to the shot for weight loss? Here are six ways, from side effects to absorption.

Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of ...

Feb 12 (Reuters) - Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a ...